Cargando…
Motor Evoked Potentials in Hereditary Spastic Paraplegia—A Systematic Review
Background: Hereditary Spastic Paraplegia (HSP) is a slowly progressive neurodegenerative disorder with no disease modifying treatment. Potential therapeutic approaches are emerging and large-scale clinical drug trials for patients with HSP are imminent. A sensitive biomarker to measure the drug eff...
Autores principales: | Siow, Sue-Faye, Cameron Smail, Ruaridh, Ng, Karl, Kumar, Kishore R., Sue, Carolyn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759520/ https://www.ncbi.nlm.nih.gov/pubmed/31620065 http://dx.doi.org/10.3389/fneur.2019.00967 |
Ejemplares similares
-
Reduced acetylated α-tubulin in SPAST hereditary spastic paraplegia patient PBMCs
por: Wali, Gautam, et al.
Publicado: (2023) -
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review
por: Siow, Sue-Faye, et al.
Publicado: (2023) -
Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature
por: Bellofatto, Marta, et al.
Publicado: (2019) -
Clinical Trial Designs and Measures in Hereditary Spastic Paraplegias
por: Trummer, Brian, et al.
Publicado: (2018) -
Hereditary spastic paraplegia with thin corpus callosum
por: Raina, Sujeet, et al.
Publicado: (2009)